Review article · 2025 · Open access

Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers

Hui Wang, Sensen Wu, Xinyu Bai, Dikang Pan, Yachan Ning, Cong Wang, Lianrui Guo, Jianming Guo, Yongquan Gu

International Journal of Nanomedicine, Volume 20, 5837–5857 · Published 1 May 2025 · DOI 10.2147/ijn.s516533

Open PDFView at the publisherCite this paper

In brief

“Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers” is a 2025 review article by Hui Wang and 8 co-authors, published in International Journal of Nanomedicine. OpenAlex counts 27 citations as of 19 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Nanomedicine.

Citations
27
Most cited in
2026 (15)
Field-weighted impact
1.84
References
177
Authors
9

Abstract

Diabetic foot ulcers (DFU) represent one of the most common side effects of diabetes, significantly impacting patients' quality of life and imposing considerable financial burdens on families and society at large. Despite advancements in therapies targeting lower limb revascularization and various medications and dressings, outcomes for patients with severe lesions remain limited. A recent breakthrough in DFU treatment stems from the development of mesenchymal stem cells (MSCs). MSCs have shown promising results in treating various diseases and skin wounds due to their ability for multidirectional differentiation and immunomodulation. Recent studies highlight that MSCs primarily repair tissue through their paracrine activities, with exosomes playing a crucial role as the main biologically active components. These exosomes transport proteins, mRNA, DNA, and other substances, facilitating DFU treatment through immunomodulation, antioxidant effects, angiogenesis promotion, endothelial cell migration and proliferation, and collagen remodeling. Mesenchymal stem cell-derived exosomes (MSC-Exo) not only deliver comparable therapeutic effects to MSCs but also mitigate adverse reactions like immune rejection associated with MSCs transplantation. This article provides an overview of DFU pathophysiology and explores the mechanisms and research progress of MSC-Exo in DFU therapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, H., Wu, S., Bai, X., Pan, D., Ning, Y., Wang, C., Guo, L., Guo, J., & Gu, Y. (2025). Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers. International Journal of Nanomedicine, Volume 20, 5837–5857. https://doi.org/10.2147/ijn.s516533

MLA 9

Wang, Hui, et al. “Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers.” International Journal of Nanomedicine, vol. Volume 20, 2025, pp. 5837–5857. https://doi.org/10.2147/ijn.s516533.

Chicago

Wang, Hui, Sensen Wu, Xinyu Bai, Dikang Pan, Yachan Ning, Cong Wang, Lianrui Guo, Jianming Guo, and Yongquan Gu. 2025. “Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers.” International Journal of Nanomedicine Volume 20: 5837–5857. https://doi.org/10.2147/ijn.s516533.

Harvard

Wang, H. et al. (2025) ‘Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers’, International Journal of Nanomedicine, Volume 20, pp. 5837–5857. doi:10.2147/ijn.s516533.

IEEE

H. Wang et al., “Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers,” International Journal of Nanomedicine, vol. Volume 20, pp. 5837–5857, 2025, doi: 10.2147/ijn.s516533.

BibTeX

@article{wang2025mesenchymal,
  title     = {{Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers}},
  author    = {Wang, Hui and Wu, Sensen and Bai, Xinyu and Pan, Dikang and Ning, Yachan and Wang, Cong and Guo, Lianrui and Guo, Jianming and Gu, Yongquan},
  journal   = {International Journal of Nanomedicine},
  year      = {2025},
  volume    = {Volume 20},
  pages     = {5837--5857},
  doi       = {10.2147/ijn.s516533},
  url       = {https://doi.org/10.2147/ijn.s516533}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease

  • diabetic foot ulcer
  • mesenchymal stem cell-derived exosomes
  • paracrine signaling
  • immunomodulation
  • angiogenesis
  • wound healing
  • collagen remodeling
  • endothelial cell migration

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Wang, H., Wu, S., Bai, X., Pan, D., Ning, Y., Wang, C., Guo, L., Guo, J., & Gu, Y. (2025). Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers. International Journal of Nanomedicine, Volume 20, 5837–5857. https://doi.org/10.2147/ijn.s516533

How many times has this paper been cited?

27 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Nanomedicine: sign in and open the PDF from this page.

Who wrote this paper?

Hui Wang, Sensen Wu, Xinyu Bai, Dikang Pan, Yachan Ning, Cong Wang, Lianrui Guo, Jianming Guo, Yongquan Gu.

What is the DOI of this paper?

10.2147/ijn.s516533, permanently at https://doi.org/10.2147/ijn.s516533. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.